---
title: "hvantk: agentic multi-omics framework for large-scale variant annotation"
id: "biorxiv-4-hvantk-an-agentic-multi-omics-framework-for-variant-annotation-and-analysis"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-4-hvantk-an-agentic-multi-omics-framework-for-variant-annotation-and-analysis"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1?rss=1"
published_at: "2026-10-21T11:50:53.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# hvantk: agentic multi-omics framework for large-scale variant annotation
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-4-hvantk-an-agentic-multi-omics-framework-for-variant-annotation-and-analysis
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1?rss=1)
- **Published At:** 2026-10-21T11:50:53.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors describe **hvantk**, a framework that standardizes variant annotation across multiple data formats and scales from desktops to clusters. - hvantk extends Hail MatrixTable and AnnData to create a common data model for genetic variant annotation, integrating diverse multi-omic sources as plugins. - The framework agentically integrates 21 public multi-omic data providers; these are implemented as plugins that do not require core changes when added. - hvantk drives analysis workflows using agent skills; the source describes use by developers, bioinformaticians, or AI agents to orchestrate workflows. - The team reanalysed three case-control cohorts: **congenital heart disease**, **developmental and epileptic encephalopathy**, and **schizophrenia**. - Re-ranking gene-based burden results with multi-omic annotations raised curated disease-gene recovery from 26% to 49% in the CHD cohort, from 40% to 48% in Epi25, and from 51% to 54% in SCHEMA among the top decile genes. - Bulk and single-cell **expression** annotations contributed most to improved gene recovery over a baseline that included burden, gene constraint, and publication count. - The paper notes heterogeneity in upstream compute needs (joint calling on clusters vs desktop gene classification) and variability in annotation resource formats and versions. - The authors declared no competing interests and listed project funders; the source did not report detailed plugin names, algorithmic parameters, or full benchmarking methodology in the abstract. - The framework is presented as extensible and scalable; the preprint is available with supplementary material and a DOI for reference.
## Clinical Analysis & Structured Key Points
[Skip to main content](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # hvantk: an agentic multi-omics framework for variant annotation and analysis [ View ORCID Profile](http://orcid.org/0000-0002-9201-7840)Enrique Audain, [ View ORCID Profile](http://orcid.org/0000-0001-6579-6941)Yasset Perez-Riverol, [ View ORCID Profile](http://orcid.org/0000-0001-9894-6897)Marc-Phillip Hitz doi: https://doi.org/10.64898/2026.10.19.760196 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Enrique Audain 1 Institute of Medical Genetics, University Medicine Oldenburg, Carl von Ossietzky University, Oldenburg, Germany; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Enrique%2BAudain%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Audain%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AEnrique%2BAudain%2B) * [ORCID record for Enrique Audain](http://orcid.org/0000-0002-9201-7840 "Open in new tab") * For correspondence: enrique.audain@uni-oldenburg.de Yasset Perez-Riverol 2 European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, UK * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yasset%2BPerez-Riverol%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Perez-Riverol%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AYasset%2BPerez-Riverol%2B) * [ORCID record for Yasset Perez-Riverol](http://orcid.org/0000-0001-6579-6941 "Open in new tab") Marc-Phillip Hitz 1 Institute of Medical Genetics, University Medicine Oldenburg, Carl von Ossietzky University, Oldenburg, Germany; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marc-Phillip%2BHitz%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Hitz%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMarc-Phillip%2BHitz%2B) * [ORCID record for Marc-Phillip Hitz](http://orcid.org/0000-0001-9894-6897 "Open in new tab") * [Abstract](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5886676/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5886676/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5886676/1) * [Supplementary material](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1.supplementary-material)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_data/node:5886676/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5886676/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Large-scale genetic variant analysis involves multiple computational steps, data formats, gene and variant annotation sources and compute requirements. Some of the steps like joint calling for large cohorts are run on large compute clusters, while gene/variant classification algorithms can be run in a desktop computer. At the same time, variant annotations such as gene expression and gene constraints metrics from gnomAD are provided in different formats, by resources that frequently change their versions. Here, we present hvantk, a framework that provides a common data model for large-scale annotation and analysis of genetic variants, by extending popular data formats such as Hail MatrixTable and AnnData. hvantk agentically integrates 21 public multi-omic data providers as plugins that a developer, bioinformatician or an AI agent can author without modifying the framework's core, drives analysis workflows using agent skills, and scales from single desktop computers to high-performance computing clusters. We used hvantk for reanalysing three case-control cohorts, comprising congenital heart disease (CHD), developmental and epileptic encephalopathy (Epi25) and schizophrenia (SCHEMA). Re-ranking of gene-based burden testing results using multi-omic annotations improved the recovery of curated disease genes from 26% to 49% in CHD, 40% to 48% in Epi25 and 51% to 54% in SCHEMA, among the top decile re-ranked genes. Expression at bulk and single-cell levels were the features contributing the most over a baseline of burden, gene constraint and publication count. ### Competing Interest Statement The authors have declared no competing interest. ## Funder Information Declared PROCEED project ERA PerMED joint Translational Call Initiative (DLR Funding reference number: 01KU1919) KinderHerzen e.V EMBL core funding Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1?rss=1#page) [ Previous](https://www.biorxiv.org/content/10.64898/2026.10.20.760375v1 "IFNα differentially disrupts stimulus-secretion coupling in pancreatic alpha and beta cells")[Next ](https://www.biorxiv.org/content/10.64898/2026.10.20.760339v1 "High-fidelity bispecific protease KRysin for deeper plasma proteomics and phosphoproteomics") Posted October 21, 2026. [ Download PDF](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1.full.pdf) Print/Save Options [Download PDF](https://www.biorxiv.org/content/biorxiv/early/2026/10/21/2026.10.19.760196.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.biorxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [Supplementary Material ](https://www.biorxiv.org/content/10.64898/2026.10.19.760196v1.supplementary-material) [ Email](https://www.biorxiv.org/ "Email this Article") [ Share](https://www.biorxiv.org/) hvantk: an agentic multi-omics framework for variant annotation and analysis Enrique Audain, Yasset Perez-Riverol, Marc-Phillip Hitz bioRxiv 2026.10.19.760196; doi: https://doi.org/10.64898/2026.10.19.760196 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Share This Article: Copy [![Twitter logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.biorxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.19.760196v1%26text%3Dhvantk%253A%2520an%2520agentic%2520multi-omics%2520framework%2520for%2520variant%2520annotation%2520and%2520analysis "Share this on Twitter") [![Facebook logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.biorxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.19.760196v1%26t%3Dhvantk%253A%2520an%2520agentic%2520multi-omics%2520framework%2520for%2520variant%2520annotation%2520and%2520analysis "Share on Facebook") [![LinkedIn logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.biorxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.19.760196v1%26title%3Dhvantk%253A%2520an%2520agentic%2520multi-omics%2520framework%2520for%2520variant%2520annotation%2520and%2520analysis%26summary%3D%26source%3DbioRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.biorxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.64898%2F2026.10.19.760196v1%26title%3Dhvantk%253A%2520an%2520agentic%2520multi-omics%2520framework%2520for%2520variant%2520annotation%2520and%2520analysis "Share on Mendeley") [ Citation Tools](https://www.biorxiv.org/ "Citation Tools") [ Get QR code](https://connect.biorxiv.org/qr/2026.10.19.760196) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.64898/2026.10.19.760196v1&count=horizontal&via=&text=hvantk%3A%20an%20agentic%20multi-omics%20framework%20for%20variant%20annotation%20and%20analysis&counturl=www.biorxiv.org/content/10.64898/2026.10.19.760196v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.biorxiv.org/content/early/recent) * [Animal Behavior and Cognition](https://www.biorxiv.org/collection/animal-behavior-and-cognition) (8164) * [Biochemistry](https://www.biorxiv.org/collection/biochemistry) (19027) * [Bioengineering](https://www.biorxiv.org/collection/bioengineering) (15171) * [Bioinformatics](https://www.biorxiv.org/collection/bioinformatics) (45246) * [Biophysics](https://www.biorxiv.org/collection/biophysics) (22958) * [Cancer Biology](https://www.biorxiv.org/collection/cancer-biology) (20077) * [Cell Biology](https://www.biorxiv.org/collection/cell-biology) (27273) * [Clinical Trials](https://www.biorxiv.org/collection/clinical-trials) (138) * [Developmental Biology](https://www.biorxiv.org/collection/developmental-biology) (14134) * [Ecology](https://www.biorxiv.org/collection/ecology) (21373) * [Epidemiology](https://www.biorxiv.org/collection/epidemiology) (2067) * [Evolutionary Biology](https://www.biorxiv.org/collection/evolutionary-biology) (25761) * [Genetics](https://www.biorxiv.org/collection/genetics) (16328) * [Genomics](https://www.biorxiv.org/collection/genomics) (23802) * [Immunology](https://www.biorxiv.org/collection/immunology) (19000) * [Microbiology](https://www.biorxiv.org/collection/microbiology) (43130) * [Molecular Biology](https://www.biorxiv.org/collection/molecular-biology) (18313) * [Neuroscience](https://www.biorxiv.org/collection/neuroscience) (94929) * [Paleontology](https://www.biorxiv.org/collection/paleontology) (711) * [Pathology](https://www.biorxiv.org/collection/pathology) (3028) * [Pharmacology and Toxicology](https://www.biorxiv.org/collection/phar
## Related Clinical Research

- [Modular workflow for biomedical entity normalization across heterogeneous ontologies](https://medichelpline.com/clinical-feed/biorxiv-2-a-modular-workflow-for-biomedical-entity-normalization-across-heterogeneous.md)
- [Results-based financing increased facility births and family planning uptake in Mayuge District, U](https://medichelpline.com/clinical-feed/medrxiv-1-effect-of-results-based-financing-on-selected-maternal-and-child-health.md)
- [Emergency diagnosis frequency and outcomes across 13 non-cancer conditions in England: analysis of](https://medichelpline.com/clinical-feed/plos-medicine-2-frequency-and-prognostic-outcomes-of-emergency-diagnosis-in-13-non-neoplastic.md)
- [NeuroSim: Multi-disorder EEG Simulator for Personalized Pattern Injection and AI Modeling](https://medichelpline.com/clinical-feed/biorxiv-5-neurosim-a-clinically-informed-multi-disorder-eeg-simulator-with-personalized.md)
- [Child marriage and later life satisfaction: longitudinal evidence from Ethiopia, India, Peru, and](https://medichelpline.com/clinical-feed/medrxiv-5-the-mental-health-impacts-of-child-marriage-in-ethiopia-india-peru-and-vietnam.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.